A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

Clinical trial NCT07230652 · RECRUITING

Trial details

NCT number: NCT07230652
Sponsor: Luye Pharma Group Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Alzheimer's Disease Psychosis

Start date: 2025-08-20
Primary completion: 2025-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.